Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients 0 19.10.2025 15:05 The Hindu An estimated 74.7% of patients treated with the combination were event-free at two years, compared to 39.4% who received surgery only, the companies said Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
